Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bauman

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
Nature Cell Biology|August 1, 2002
Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duoAndrea L Bauman, John D Scott
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Mexiletine: a new type I antiarrhythmic agentB J Schrader, J L Bauman
The Journal of Pediatrics|November 1, 1971
Hydrocephalus in Apert's syndromeG R Hogan, M L Bauman
Pharmacotherapy|September 19, 2023
Standards of practice to advance the quality of health careC Lindsay DeVane, Jerry L Bauman
Novartis Foundation Symposium|October 3, 2003
The neuropathology of the autism spectrum disorders: what have we learned?Margaret L Bauman, Thomas L Kemper
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Cardiovascular Effects of Cocaine: Focus on HypertensionCarolyn S. Brecklin, Jerry L. Bauman
Pharmacotherapy|May 15, 2001
Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based reviewD E Hilleman, A L Bauman
Pharmacoeconomics|May 8, 1995
Prescribing trends and pharmacoeconomic considerations in the treatment of arrhythmias. Focus on atrial fibrillation and flutterB G Phillips, J L Bauman
Geriatric Nursing (New York, N.Y.)|January 1, 1984
Common concern. Geriatric nurse practitioners: how are they doing?T Rogers, L Metzger, L Bauman
The New England Journal of Medicine|January 13, 1977
Intravenous phenytoinJ L Bauman, J K Siepler
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
Nature Cell Biology|August 1, 2002
Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duoAndrea L Bauman, John D Scott
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Mexiletine: a new type I antiarrhythmic agentB J Schrader, J L Bauman
The Journal of Pediatrics|November 1, 1971
Hydrocephalus in Apert's syndromeG R Hogan, M L Bauman
Pharmacotherapy|September 19, 2023
Standards of practice to advance the quality of health careC Lindsay DeVane, Jerry L Bauman
Novartis Foundation Symposium|October 3, 2003
The neuropathology of the autism spectrum disorders: what have we learned?Margaret L Bauman, Thomas L Kemper
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Cardiovascular Effects of Cocaine: Focus on HypertensionCarolyn S. Brecklin, Jerry L. Bauman
Pharmacotherapy|May 15, 2001
Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based reviewD E Hilleman, A L Bauman
Pharmacoeconomics|May 8, 1995
Prescribing trends and pharmacoeconomic considerations in the treatment of arrhythmias. Focus on atrial fibrillation and flutterB G Phillips, J L Bauman
Geriatric Nursing (New York, N.Y.)|January 1, 1984
Common concern. Geriatric nurse practitioners: how are they doing?T Rogers, L Metzger, L Bauman
The New England Journal of Medicine|January 13, 1977
Intravenous phenytoinJ L Bauman, J K Siepler
Pageof 22